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Nicotinic acid adenosine dinucleotide phosphate (NAADP) 3 was first discovered as a calcium mobilizer in sea urchin eggs in 1995 (1) . Since then, a large body of evidence has shown that it is a universal second messenger, regulating intracellular Ca 2ϩ concentrations by mobilizing acidic Ca 2ϩ stores in a wide range of cells (for review, see Refs. [2] [3] [4] . But until now, some aspects of NAADP signaling still remain enigmatic, including its biosynthesis.
CD38 is an interesting protein that has attracted attention for decades, from its original use as a cell-typing marker (5) , its functioning as a signaling enzyme (6, 7) , and as a surface receptor (8) , to being a therapeutic target for cancer immunosuppression (9) (for review, see Ref. 10 ). We first proposed that CD38 is an enzyme because of its sequence similarity with Aplysia ADP-ribosyl cyclase, the first enzyme known to catalyze the synthesis of the Ca 2ϩ -messenger, cyclic ADP-ribose (cADPR) from NAD ϩ (6, 7, 11, 12) . Subsequent work establishes that CD38 not only can cyclize NAD to cADPR, but also catalyze a separate base-exchange reaction, exchanging the nicotinamide group of NADP with nicotinic acid (NA) to produce NAADP (2, 7) . To date, CD38 and the base-exchange reaction remain the only known pathway for the biogenesis of NAADP.
The mechanism of how CD38 can catalyze multiple reactions has been well studied and understood, including the structural determinants underlying the acidic requirement of the baseexchange reaction (13) . The mechanism of how CD38 synthesizes NAADP in cells, however, remains to be elucidated. CD38 is generally believed to be a type II transmembrane protein with its catalytic carboxyl (C)-domain facing outside (14) . We have recently documented that type III CD38 of opposite membrane orientation also exists in cells (15, 16) . Because the base-exchange reaction requires acidic conditions, type III CD38 with its catalytic C-domain facing the neutral cytosol may not be effective for NAADP synthesis. The major acidic compartment in cells is the endolysosome. It is possible that the surface type II CD38 is delivered to the endolysosomal compartment through endocytosis and is exposed to the acidic environment suitable for NAADP synthesis. A critical requirement for such a proposal is that CD38 can survive the highly degradative environment of the endolysosomes. In this work, we directly address this issue by constructing and directing CD38 into the endolysosomal compartment by two independent procedures. The results show that CD38 not only survives lysosomal degradation but is also fully active in making NAADP, which activity is substantially enhanced by the supplementation of NA. The results indicate that the type II lysosomal CD38 can be the enzyme catalyzing the endogenous production of NAADP and suggest that the compartmentation may allow NAADP synthesis to be regulated by substrate access instead of enzyme activation.
Results

Endocytosis of CD38 triggered by nanobodies (Nbs)
We have previously developed a series of Nbs targeting three separate epitopes on the C-domain of CD38 and have used them to produce immunotoxins that are highly effective in killing CD38
ϩ -multiple myeloma cells (17) . This suggests that the Nbs may trigger CD38 endocytosis efficiently by binding to the surface type II CD38. To determine whether Nb treatment could be a specific means for directing CD38 into the endolysosomal compartments, we incubated human LP-1 myeloma cells that expressed high levels of surface CD38 with Nb-1053 or Nb-551, two Nbs targeting different CD38 epitopes (17) , and measured the extent of endocytosis of surface CD38. An unrelated Nb against GFP, NbGFP (18) was used as a negative control.
The endocytosis experiments were carried out in three steps as diagramed in Fig. 1a . The first step was incubation of the Nbs with the cells on ice to stop endocytosis and allow saturated binding of Nbs to the surface CD38. The incubation temperature was then raised to 37°C in the presence of extra Nbs to commence endocytosis. At various times afterward, endocytosis was stopped on ice and all the extracellular Nbs that were not internalized were stripped by a glycine treatment. The quantification of the internalized Nbs was done by Western blots. As shown in the panels labeled Nb in Fig. 1b , increasing amounts of Nb-1053 (panels labeled Nb-1053) or Nb-551 (panels labeled Nb-551) were measured in the cells during the 15-min period of Figure 1 . Nanobodies triggered CD38 endocytosis. a, schematic diagram of the protocol for detecting and quantifying the internalized Nbs. b, internalization of Nbs detected by Western blots. LP-1 cells were incubated with Nbs followed by the internalization protocol (a) and Western blots probing CD38, Nbs (anti-Myc), and GAPDH. c, binding capacity and specificity of the fluorescently labeled Nbs. WT and CD38-KO LP-1 cells were incubated with AF488-labeled Nb-1053, Nb-551, or NbGFP, as a negative control. The representative fluorescent images merged with the bright field are shown. d, visualization of internalized Nbs. HeLa cells stably expressing CD38 were incubated with Nb-1053 and subjected to the internalization protocol and immunostaining with anti-CD38. Confocal micrographs of CD38 (purple) and Nb-1053 (green) are shown. Co-localization of both is colored cyan. Total, without glycine-stripping; internal, with glycine-stripping. e, LP-1 cells were incubated with AF488-labeled Nb-1053, followed by the internalization protocol and analyzed with flow cytometry. f, the percentages of the internalized Nbs were plotted versus the time of endocytosis and the internalization rate constants (K e ) were calculated as described in the text.
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endocytosis. That NbGFP was not internalized (panels labeled NbGFP) indicates that endocytosis was CD38 specific.
To facilitate the quantification of the endocytosed Nbs, we labeled the Nbs with an amine-reactive, pH insensitive green fluorescent dye, Alexa Fluor TM 488 succinimidyl esters. That the labeling did not interfere with the specific binding of the Nbs to the surface CD38 was shown by the staining of the WT (CD38 ϩ ), but not CD38-knockout (CD38 Ϫ ), LP-1 cells by the fluorescent Nbs (Fig. 1c) .
The Nb-induced endocytosis of CD38 was a general occurrence not unique to LP-1 cells, and was observed in the HeLa and HEK293 cells as well. This is shown in Fig. 1d using HeLa cells transfected and expressing surface CD38. Endocytosis was induced as described above, except using the fluorescent Nbs instead. After glycine stripping, confocal imaging showed the internalized green signals in both cells treated with fluorescent Nb-1053 (Fig. 1d, white arrow) or Nb-551 (Fig. S1b ), but not with fluorescent NbGFP (Fig. 1b) . In the control without the warming step (Fig. 1d , Endocytosis 0 min, internal) to allow endocytosis, no internal signals were observed. The same figure also shows the effectiveness of the glycine-stripping procedure to eliminate all surface-bound Nbs (Fig. 1d , internal, green fluorescence). Cells were also stained with anti-CD38 (Fig. 1d , purple signals), and the internalized Nbs (green) showed substantial co-localization with CD38 (Merge, cyan). The results indicate that the Nb-induced endocytosis observed was specifically mediated by the binding of the Nb to the surface CD38 and that the internalized Nbs and CD38 were substantially associated with each other in the intracellular organelles. This validated the use of the internalized fluorescent Nb as a measure for the endocytosis of CD38.
In addition to HeLa cells, similar results were also obtained using HEK293 cells (Fig. S2) , confirming that the specific binding of the Nb to the surface CD38 is generally effective in inducing its endocytosis, irrespective of the cell type. All three cell types were used in this study. HeLa and HEK293 cells do not express CD38 and allow the study of various CD38 constructs described later without the interference of the endogenous CD38, whereas the LP-1 cell is used as a model for the naturally expressed CD38.
To quantify the endocytosis process in LP-1 cells, flow cytometry was used to obtain the Nb fluorescence distribution in the cell populations (Fig. 1e) . Before warming to initiate endocytosis and without glycine-stripping, all cells had high Nb fluorescence (x axis, Fig. 1e , bottom histogram) with a fluorescence value around 2.5 ϫ 10 4 units at the peak of the cell histogram. After glycine-stripping, essentially all the bound Nbs were removed, with the corresponding large reduction in the fluorescence at the cell peak (Fig. 1e, light blue line, 0) . After warming, internalization progressed and the fluorescence at the cell peak increased for the first 9 min and then stabilized (Fig. 1e, 3-15 min) . The ratios of the fluorescence at the cellpeak value to that of the total (before stripping) represents the percentage of the internalized Nb at various times and were plotted in Fig. 1f . The slope of the first three points (0, 3, 6 min) of the plot was used to determine the internalization rate constants (K e ) as previously described (19) . The K e values of Nb-1053 and Nb-551 were similar at around 0.007 min Ϫ1 , indicating about 0.7% of the initial surface CD38 was internalized in a minute.
Nanobody-induced endocytosis of CD38 is mainly via the clathrin-dependent pathway
Pharmacological inhibition and RNAi were then used to decipher if the Nb-induced internalization of CD38 was through the clathrin-mediated endocytosis (CME) or clathrinindependent endocytosis (CIE) (20) . Inhibitors of CME, phenylarsine oxide (PAO), and Pitstop 2 (21) at sufficient concentrations, substantially blocked the Nb-induced endocytosis in HeLa cells (Fig. 2a) , whereas methyl-␤-cyclodextrin (M␤CD) or Filipin (21), inhibitors of CIE, did not, indicating that the Nb-induced endocytosis was mainly going through the CME pathway.
This was further validated by RNAi, using siRNA targeting clathrin heavy chain (CHC) or caveolin-1 (Cav1), a principal component of caveolae membranes involved in CIE (22) . Western blots confirmed the knockdown efficiency (Fig. 2b) . The percentages of CD38 internalized at various time points after treatment with Nb-1053 were shown in Fig. 2c . The data indicated that CHC knockdown impaired the endocytosis, whereas knockdown of Cav1 showed little effect.
If the Nb-induced endocytosis is indeed mediated by CME, the internalized Nbs should co-localize with clathrin (CHC). This is the case as shown in Fig. 2d . Merging the fluorescence micrographs showed substantial overlap of the Nb and CHC fluorescence in a HeLa cell after 30 min of induced endocytosis. The statistical analysis of the co-localization of the two signals for a number of cells showed a significant increase after Nb-1053 treatment (Fig. 2e) . In contrast, the co-localization between Nb-1053 and Cav1 significantly decreased (Fig. 2, f and  g ). The data confirmed that the Nb-1053-induced endocytosis of CD38 was mediated mainly by the clathrin-dependent pathway.
The internalized CD38 is in the endolysosomes
To determine whether the internalized CD38 reached the endolysosomes, we co-stained the internalized CD38-Nb complex in HeLa cells with two marker proteins, Rab5 for early endosomes and LAMP1 for lysosomes. As the confocal images and statistical analyses as shown in Fig. 3 , a-d, the co-localization of CD38 with both Rab5 and LAMP1 increased significantly after endocytosis induced by Nb-1053, indicating that the CD38-Nb complexes entered endolysosomes after internalization.
We further checked the influence of bafilomycin A1 (Baf-A1), a specific lysosomal inhibitor (23), on the Nb-induced endocytosis. In LP-1 cells pretreated with Baf-A1, the percentage of internalized Nb-1053, as determined by the fluorescence assay described above, increased more rapidly as compared with the control without pretreatment (Fig. 3e) . Similar results were obtained using Western blot analysis to determine the internalized Nb-1053 (Fig. 3f, black bars) . Blocking the lysosomal degradation thus inhibited breakdown of the endocytosed Nbs, resulting in its accumulation. Notably and in contrast, the total amount of CD38 (Fig. 3f, open bars) stayed relatively unaffected during Baf-A1 treatment. That Baf-A1 did not cause Lysosomal CD38 and NAADP biogenesis the accumulation of CD38 during the indicated treatment period suggests that the protein is relatively stable against lysosomal degradation. Results presented later will further prove this directly.
Endocytosed CD38 increases the cellular NAADP levels
We proceeded to determine whether the induced endocytosis resulted in elevation of cellular NAADP levels. LP-1 cells were treated with Nb-1053 and the NAADP levels were measured at various times afterward by the cycling assay we developed previously (24) . As shown in Fig. 4a , in the presence of NA, the co-substrate for the base-exchange reaction, NAADP levels increased progressively, whereas the NbGFP-treated cells did not show a significant increase. The total amounts of CD38 stayed constant during all treatments (Fig. 4b) . The inset in Fig.  4a shows a significant increase in cellular NAADP levels, albeit subdued, even without supplementing the cells with exogenous NA.
NA is vitamin B 3 and is naturally present in vivo, although its concentration in the culture media (Iscove's modified Dulbecco's medium/fetal bovine serum) may be low and thus requiring supplementation. That the presence of NA can greatly enhance the elevation of cellular NAADP levels (compare Fig. 4a and inset) raises a novel possibility that the compartmentation of CD38 in the endolysosomes can allow the cellular NAADP levels to be regulated, not by activation of the enzymatic activity of CD38, but by access of the substrate NA. This proposal will be discussed in more detail below.
It has previously been shown that natural ligands such as NAD can also induce the internalization of CD38 (25, 26) . We confirmed that treatment with NAD did induce internalization of CD38 and that the internalized CD38 were co-localized with lysosomes by immunostaining, as shown in Fig. S3a . The treatment of NAD also induced a progressive increase in cellular NAADP levels, which were further enhanced in the presence of NA (Fig. S3b) . It thus appears that the endocytosis of CD38 and elevation of NAADP is a general process, not limited only to that observed with the nanobody treatment.
Engineering a lysosome-targeting CD38, lyso CD38
Results described above indicate that surface CD38 directed into the endolysosomal compartment by endocytosis not only can survive the degradative environment but is also active in producing cellular NAADP. To provide direct support, we constructed a lysosomal CD38 (lyso CD38) specifically targeted to express in the lysosomes. Fig. 5a diagrams the construct. It is a fusion protein containing an N-terminal signal peptide for endoplasmic reticulum (ER) trafficking and a C-terminal segment of LAMP1 (Ser-381 ϳ Ile-417) for lysosomal retention, and in between was spliced the EGFP-tagged C-domain of CD38 (EGFP-sCD38). EGFP-sCD38 was constructed as described previously by replacing the N-terminal tail and transmembrane segment of the native CD38 with EGFP (Fig. 5a, EGFP-sCD38) (27) . We have previously shown that EGFP-sCD38 is expressed in the cytosol and is not glycosylated (27) . Also constructed was the fulllength WT CD38 tagged with EGFP at the C terminus (CD38- Lysosomal CD38 and NAADP biogenesis EGFP). These constructs were introduced to HEK293 cells by lentivirus infection, as described under "Experimental procedures" and the expression of all four proteins was found to be very efficient (Fig. 5, b and e) .
Native CD38 is a transmembrane protein glycosylated in the ER and Golgi apparatus (27, 28) . Consistently, de-glycosylation of CD38-EGFP by EndoH resulted in reduction in size as shown by the Western blot in Fig. 5b (3rd and 4th lanes) . As a control, EGFP-sCD38 is soluble, made in the cytosol, and is thus not glycosylated. EndoH treatment indeed did not affect its size (Fig. 5b, 5th and 6th lanes) . Lyso CD38 has the same soluble EGFP-sCD38 sandwiched between the ER and lysosomal sorting signals. EndoH treatment resulted in size reduction (Fig. 5b,  1st and 2nd lanes) , indicating it was translated and glycosylated in the ER and Golgi apparatus such as the WT CD38.
Immunostaining and confocal imaging of the HEK293 cells showed that lyso CD38 co-localized with LAMP1 (Fig. 5c, first  row) . Correspondingly, the 2D scattered graph of lyso CD38 
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and LAMP1 fluorescence showed that the points fall mainly along a 45-degree line (Fig. 5d, first graph) , indicating good co-localization between lyso CD38 and LAMP1. Consistently, the Pearson's correlation obtained from 21 cells reached 0.7135 Ϯ 0.0279, with unity indicating perfect correlation. These results indicate that lyso CD38 was expressed predominantly in lysosomes. In contrast, EGFP and EGFP-sCD38 were cytosolic, whereas CD38-EGFP was in the plasma membrane (Fig. 5, c and d, 2nd to 4th row) . Their Pearson's correlation values were all low at about 0.2.
The lysosomal localization of lyso CD38 was further confirmed by testing the changes of its EGFP fluorescence following lysosomal alkalinization. The EGFP fluorescence is pH-sensitive and increases with alkalinization. Ammonium chloride (NH 4 Cl) is a lysosomotrophic agent that can effectively alkalinize the endolysosome compartments (29) . As seen in the micrographs and the time courses of the digitized fluorescence of the cells (Fig. 5, e and f) , the EGFP fluorescence of the lyso CD38-expressing cells rapidly (in 5 s) increased after NH 4 Cl addition, but not those expressing the other constructs. That the EGFP fluorescence was responsive to alkalinization of the lysosomal pH, indicated that the EGFP-sCD38 portion of lyso CD38 was facing the lumen of the lysosomes. In contrast, the EGFP fluorescence signals (Fig. 5f ) of the other three cell lines were not altered, consistent with their EGFP tags facing either the cytosol or the external medium and thus not affected by NH 4 Cl.
The engineered lyso CD38 is enzymatically active and effectively elevates NAADP in cells
That the fluorescence of lyso CD38 could be readily detected indicates it is intact and stable inside the endolysosomes. To determine whether it is enzymatically active, lysates were prepared from the four cell lines expressing various constructs. The amounts of the various forms of CD38 expressed in HEK293 cells were measured by Western blots (Fig. 6a) . The NADP produced by the reversed base-exchange activity was assayed using NAADP and nicotinamide as substrates as described under "Experimental procedures." As shown in Fig.  6b , lyso CD38, CD38-EGFP, and EGFP-sCD38 were all active, whereas EGFP, as a negative control, was not. After normalizing with the amount of the expressed CD38 (Fig. 6a) , lyso CD38 showed similar activity as the WT CD38 (Fig. 6c, open bars) . Also measured was the NAD produced by the reversed ADPribosyl cyclase activity of the lysates using cADPR and nicotinamide as substrates (Fig. 6c, black bars) . Consistently, both lyso CD38 and WT CD38 had similar cyclase activities.
We next investigated if lyso CD38 could elevate the cellular NAADP levels. HEK293 cells expressing either the lyso CD38 or the WT CD38 were supplemented with NA at pH 5 to facilitate its entry into the cells. The time courses of subsequent elevation of cellular NAADP levels are shown in Fig. 6d . Cells expressing lyso CD38 showed a progressive increase in cellular 
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NAADP levels. Cells expressing WT CD38 did not show much change, which is consistent with it having a type II orientation with the catalytic domain facing outside and thus requires endocytosis to enter the endolysosomes for NAADP production (cf. Fig. 4 ).
Discussion
NAADP is the most potent Ca 2ϩ messenger known to date and mediates a wide range of biological functions (30, 31) . How it is produced in cells, however, is not well understood. Despite sparse literatures suggesting other unknown enzymes might be involved (32, 33) , CD38 is still the only one fully characterized (7) and documented to synthesize NAADP in a variety of cells (34 -36) . We have shown that the base-exchange reaction catalyzed by CD38 to produce NAADP from NADP and NA requires an acidic pH (7). This is because of the electrostatic repulsion of the negatively charged NA (at neutral pH) and the acidic residues of CD38, Glu-146 and Asp-155, preventing access of the substrate to the catalytic site (13) . Because the major acidic compartment in cells is the endolysosomes, it has long been suggested that endocytosis can deliver CD38 into an environment suitable for NAADP production (2-4, 7, 25, 35, 37) .
This study addresses the issue directly and uses two independent means to deliver CD38 into the endolysosomes. First, Nbs raised specifically against different epitopes on the C-domain of CD38 (17, 38) were used to induce endocytosis. Up to 7-8% of either endogenously (LP-1) or exogenously (HeLa and HEK293) expressed CD38 can be effectively delivered to the endolysosomes in 10 min. Second, we utilized the lysosomal sorting signal to direct EGFP-tagged CD38 to the lumen of lysosomes. The construct was efficiently expressed in the endolysosomes and its fluorescence was responsive to luminal pH changes.
CD38 delivered to the endolysosomes by either method was shown to be stable, enzymatically active, and can elevate cellular NAADP contents, fulfilling the critical requirement for it to be part of the endogenous mechanism for NAADP synthesis. Although we used Nb to artificially activate endocytosis, the process is naturally occurring continuously in cells during membrane recycling and retrieval, as well as activated by natural ligands. Indeed, external NAD has been shown to induce internalization of CD38 (25) and natural ligands of CD38 have been identified, including CD31 (39) . For cells normally express surface CD38, the endogenous endocytosis should result in the constant presence of endolysosomal CD38 for NAADP synthesis.
In this study, we emphasize the use of the CD38 nanobody as a tool. But it should be noted that the CD38 antibody is a well- Figure 6 . lyso CD38 is active in making NAADP in vitro and in cells. a, the levels of three forms of CD38 were analyzed in the four HEK293 cell lines stably expressing EGFP, lyso CD38, CD38-EGFP, and EGFP-sCD38 by anti-CD38 or anti-GAPDH as a loading control. b, the time courses of the production of NADP by the reversed base-exchange activity in same lysates used in (a) were measured as described under "Experimental procedures." c, the NAD produced by the reversed cyclase activity of the lysates used in a were measured as described under "Experimental procedures." The values were normalized to the amounts of the CD38 proteins expressed, presented as nM NAD(P)/min/unit of CD38, and compared with that of the reversed base-exchange activities. d, HEK293 cells expressing lyso CD38 or CD38-EGFP were treated with 10 mM NA at pH 5. The courses of the change in NAADP level were measured and presented as pmol of NAADP/mg of proteins.
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documented physiological stimulus that can produce multiple biological effects, including the activation of T cells (40) , suppression of B lymphopoiesis (41) , activation of c-cbl in myeloid cells (42) , and stimulation of insulin release in pancreatic islets (43) . The results described in this study should be relevant for elucidating the mechanisms of these effects.
CD38 is a highly unusual protein. It catalyzes different reactions to produce cADPR and NAADP that target, respectively, the endoplasmic and the lysosomal Ca 2ϩ -stores in cells. The cyclization reaction that produces cADPR occurs at neutral pH, whereas the base-exchange reaction for producing NAADP requires an acidic condition (7). More unusually, we have recently shown that CD38 naturally exists in two opposite membrane orientations. On the cell surface, it is expressed as a type II membrane protein with its catalytic C-domain facing outside. Intracellularly, it is expressed as a type III protein with its C-domain facing the cytosol (16) . The C-domain of type III CD38 interacts specifically with CIB1, a cytosolic regulator protein, and results in modulation of the cellular cADPR levels (16) . Because of its membrane topology, the catalytic domain of the Type II CD38, either expressed on the cell surface or delivered to the endolysosomes by endocytosis, is excluded from the cytosol and is thus unlikely to be regulated by cytosolic mechanisms. Controlling substrate access to the compartmentalized CD38 in the endolysosomes would be a novel means to regulate NAADP production, without the need to modulate its enzymatic activity. Consistent with this proposal, we showed in this study that supplementing the cells with NA indeed can enhance NAADP production by the endolysosomal CD38, indicating the substrate was limiting. To facilitate its entry into the cells, we lowered the pH to protonate NA. Several natural transporters for NA have been described, including hOAT10 (44), bilitranslocase (45), SMCT1 (46) , and AE2 (47) . Likewise, entry of NADP could be mediated by transporters like the connexin 43 hemi-channel, which has been shown to transport NAD and its permeability is regulated by phosphorylation (48). Physiological activation of these transporters could increase access of the substrates to the endolysosomes and elevate cellular NAADP levels. It remains to be determined whether this could be a novel way to regulate the messenger level in cells, not by activating the synthesizing enzyme but by increasing the substrate availability.
Experimental procedures
Reagents and antibodies
PAO were from Abcam. GAPDH antibody, Pitstop 2, M␤CD, filipin, Baf-A1, nicotinic acid, and reagents for cycling assay were purchased from Sigma. LAMP1 antibody (number 9091) and Rab5 antibody (number 3547) were from CST. CHC antibody (sc-271253) and Cav1 antibody (sc-894) were from Santa Cruz Biotechnology. Myc-tag mouse mAb were from Genescript. Anti-CD38 antibody were homemade (16) . Horseradish peroxidase-or Alexa fluorophores-conjugated secondary antibodies were from Thermo Fisher Scientific.
Cells
HeLa, HEK293, and HEK293T cells were purchased from ATCC. The LP-1 cell line was a gift from Annie An (Peking University, China). Cell lines were authenticated by genetic profiling with polymorphic short tandem repeat loci. The cells were maintained in DMEM (HeLa, HEK293, HEK293T, and stable cell lines originated from these cells) or Iscove's modified Dulbecco's medium (LP-1 and CD38-KO/LP-1 (16)), supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin (Thermo Fisher Scientific), and cultured at 37°C in a humidified atmosphere with 5% CO 2 .
Constructs and siRNAs
The prokaryotic expression vectors of Myc-tagged Nbs and constructs encoding EGFP, EGFP-sCD38, and CD38-EGFP are referred to in our previous reports (17, 27) . The lyso CD38 was constructed by fusing the signal peptide for ER trafficking, EGFPsCD38, and the lysosome retention signal sequence (the nucleic acid and protein sequences are in the supporting data) and the chimeric gene was then subcloned to pLenti-puro viral vector (Addgene, number 39481) by LR ligation through pENTR1A-GFP-N2 (FR1) (Addgene, number 19364). For expression of CD38 without tag, the CD38 gene was cloned to pLenti-puro with the strategy described above.
siRNAs were synthesized in GenePharma. Sequences were 5Ј-UUCUCCGAACGUGUCACGUtt-3Ј (for scramble), 5Ј-GCAAUGAGCUGUUUGAAGAtt-3Ј (for CHC), and 5Ј-CCUGAUUGAGAUUCAGUGCtt-3Ј (for Cav1).
Preparation and labeling of nanobodies
Nanobodies, Nb-1053, Nb-551, and NbGFP, were expressed and purified as described previously (17) . To label the Nbs, 200 g of purified Nbs were incubated with Alexa Fluor TM 488 (AF488) NHS ester (A20000, Thermo Fisher Scientific) at a molar ratio of 1:4 in 0.2 M sodium bicarbonate buffer, pH 8.3, overnight at 4°C. The reaction was stopped by 20 mM Tris and the unreacted probes were removed by filtration using Centricon filters (Millipore, number MA54455). The labeled AF488-Nbs were aliquoted and stored at Ϫ80°C until use.
Transfection and infection
The siRNAs were transfected to HeLa cells using Lipofectamine RNAiMAX (Thermo Fisher Scientific). Lentiviral particles were prepared by transfecting HEK293T cells with pLenti-vectors, pMD2.G and psPAX2 with Lipofectamine 2000 (Thermo Fisher Scientific), and cell infection was performed as described previously (27) followed by puromycin selection.
Internalization assays and treatments with inhibitors
LP-1 cells were incubated with AF488-conjugated Nbs (50 nM) for 40 min at 4°C, then shifted to 37°C to initiate internalization. A portion of cells were removed at different time points and the surface-bound Nb was stripped with the glycine-stripping buffer (200 mM glycine, 150 mM NaCl, pH 3.0) at 4°C followed by Western blots or flow cytometry (CytoFLEX, Beckman Coulter). HeLa or HEK293 cells expressing CD38 were pretreated with different inhibitors of endocytosis in Hanks' balanced salt solution (Thermo Fisher Scientific) for 3.5 h followed by the one-half hour internalization step triggered by AF488-conjugated Nb-1053 (1053-AF488) using normal growth conditions. The cells were collected after detachment by treating Lysosomal CD38 and NAADP biogenesis with 0.05% trypsin-EDTA (Thermo Fisher Scientific) at 37°C for 4 min and subjected to flow cytometry to quantify the internalized Nb after the glycine-stripping step as described above. To disrupt lysosomal degradation, the cells were pre-treated with 1 M Baf-A1 for 4 h at normal conditions if not specialized in the text.
Immunofluorescence microscopy
HeLa cells stably expressing CD38 were seeded onto coverslips coated with 0.001% poly-L-lysine in 24-well plates 24 h before experiments. The cells were incubated with Nb-1053 at 4°C for 40 min, and then shifted to 37°C for a 30-min internalization step. Then the cells were washed with pre-cold PBS once or 3 times with glycine-stripping buffer and then fixed with the indicated fixation buffer according to the manufacturers' instructions of the antibodies used. Immunostaining was done with the indicated antibodies and images were acquired using a LSM510 confocal microscope (Zeiss).
For real-time recording of the EGFP fluorescence, HEK293 cells were attached to poly-L-lysine pre-treated coverslips and imaged using an inverted microscope (TI-E, Nikon, Japan) equipped with a ϫ40 oil-immersion objective (S Fluor 1.3 NA, Nikon). The fluorescence from individual cells was digitized and recorded continuously for around 3 min using the software NIS-Elements.
Measurement of intracellular NAADP levels
It was done as described previously (24, 49) . Briefly, cells were lysed with 300 l of 0.6 M perchloric acid. The precipitated proteins were removed and re-dissolved in 1 M NaOH and quantified with the Bradford method. The nucleotide extracts were subject to a cycling assay after neutralization with a tri-noctylamine/chloroform mixture. The amounts of NAADP measured were normalized to the total amount of protein determined with the Bradford assay.
Measurement of base-exchange and ADP-ribosyl cyclase activities
The cell lysates of HEK293 cells expressing different fusion proteins were washed with PBS using Centricons several times to remove the endogenous NAD and NADP. A portion of the cleaned lysates was used for Western blotting to quantify the amount of CD38 in a unit volume of the lysates. A half-g portion of the cleaned lysate was incubated with 20 mM nicotinamide and 100 M NAADP (for the reversed base-exchange activity) or cADPR (for the reversed cyclase activity) for various periods to produce NADP or NAD, respectively, which was detected by the cycling assay as described previously (49). The activities were presented as nM NAD(P)/min/unit of CD38.
Quantification and statistical analysis
Quantification of the Western blots was performed with ImageJ software. Imaris Bitplane software was used for colocalization analysis of the confocal signals. NIS-Elements software was used in quantification of the fluorescence in live-cell imaging. Statistical analysis was done with the GraphPad Prism software and the significance of differences was analyzed by the unpaired Student's t test. Data shown in reported figures are mean Ϯ S.E. from at least three repeats. 
